Medicamentous correction of endothelial dysfunction in patients with arterial hypertension and inflammatory diseases of joints
##plugins.themes.bootstrap3.article.sidebar##
##plugins.themes.bootstrap3.article.main##
Abstract
The goal of the present study was to investigate the state of endothelial function in patients with arterial hypertension and rheumatoid arthritis and to assess the capabilities of its correction by means of L-lysine aescinat.
Material and methods. The study was conducted in two phases. At the first phase we conducted assessment of endothelial function state in patients with arterial hypertension combined with rheumatoid arthritis, in patients with rheumatoid arthritis and in patients with arterial hypertension. For evaluation of endothelial function we used ultrasound method for determining the endothelium-dependent vasodilation of the brachial artery. In the second phase of conducted study we examined the effectiveness of the addition of L-lysine aescinat to the basic antihypertensive and anti1inflammatory therapy in the correction of endothelial function in patients of the above mentioned groups.
Results. It was determined that patients with rheumatoid arthritis in combination with arterial hypertension have a more significant endothelial dysfunction compared with those one in patients with rheumatoid arthritis without hypertension and subjects with hypertension without rheumatoid arthritis. Intravenous administration of L-lysine aescinat against the background of the basic therapy resulted significant (p <0,05) improvement of the vascular wall state (increases endothelium-dependent vasodilation).
Conclusion. In patients with combined pathology we revealed more severe endothelial dysfunction than for each individual disease. For correction of endothelial function in the background of the basic therapy of both diseases it is expedient to use the L-lysine aescinat.
##plugins.themes.bootstrap3.article.details##
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright and grant the journal the first publication of original scientific articles under the Creative Commons Attribution 4.0 International License, which allows others to distribute work with acknowledgment of authorship and first publication in this journal.
References
Галютіна О.Ю. Функція ендотелію у хворих на ревматоїдний артрит, її зв’язок з факторами ризику ІХС / О.Ю. Галютіна, М.А. Станіславчук // Вісник Вінницького національного медичного університету. – 2007. – Т. 2/1 (11). – С. 632–637.
Коваленко В.Н. Особенности патогенеза и клинического течения атеросклероза у больных с системными воспалительными заболеваниями / Н.В. Коваленко, Т.В. Талаева, Е.А. Гармиш, В.В. Братусь // Укр. Кардіол. журн. – 2011. – No 1. – С. 102–120.
Насонов Е.Л. Циклооксигеназа-2 и кардиоваскулярная патология / Насонов Е.Л. // Сердце. – 2004. – No 4. – С. 209–212.
Brunner H. Endothelial function and dysfunction, part II: association with cardiovascular risk factors and diseases: a statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension / H. Brunner, J.R. Cockcroft, J. Deanfield [et al.] // J. Hypertens. – 2005. – Vol. 23. – P. 233–246.
Dessein P.H. Influence of nonclassical cardiovascular risk factors on the accuracy of predicting subclinical atherosclerosis in rheumatoid arthritis / P.H. Dessein, G. R. Norton, A.J. Woodiwiss [et al.] // Rheumatol. – 2007. – Vol. 34 (5). – P. 943–951.
Foster W. Inflammation and microvascular and macrovascular endothelial dysfunction in rheumatoid arthritis: Effect of treatment / W. Foster, D. Carruthers, G.Y.H. Lip, A.D. Blann // J. Rheumatol. – 2010. – Vol. 37. – P. 711–716.
Gabriel S.E. The epidemiology of rheumatoid arthritis / S.E. Gabriel // Rheum. Dis. Clin. North Am. – 2001. – Vol. 27. – P. 269–281.
Hannawi S. Inflammation predicts accelerated brachial arterial wall changes in patients with recent-onset rheumatoid arthritis / S. Hannawi, T.H. Marwick, R. Thomas // Arthritis Res. Ther. – 2009. – Vol. 11. – P. 51.
Naranjo A. Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study / A. Naranjo // Arthritis Res Ther. – 2008. – Vol. 10. – P. 30.
Peterson M.J. Cardiovascular risk management in patients with rheumatoid arthritis and other types of inflammatory arthritis – EULAR TASK FORCE «Cardiovascular risk management in RA». / M.J. Peterson, D.P. Symmons, D.W. McCarrey [et al.] // Ann. Rheum. Dis. – 2008. – Vol. 67(II). – Р. 310.
Yiu K.-H. Role of сirculating endothelial progenitor cells in patients with rheumatoid arthritis with coronary calcification / K.-H. Yiu, S. Wang, M.-Y. Mok [et al.] // J. Rheumatol. – 2010. – Vol. 37. – P. 529–535.
